Trade Summary

3 days ago, Hite Christopher, serving as EVP & Chairman, Partnering at Royalty Pharma plc (RPRX), sold 150,000 shares at $54.40 per share, for a total transaction value of $8,159,276.82. Following this transaction, Hite Christopher now holds 559,399 shares of RPRX.

This sale represents a 21.14% decrease in Hite Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 at 5:11 PM ET, 2 days after the trade was made.

Royalty Pharma plc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.